Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 31 October 2003:
Vol. 302. no. 5646, pp. 871 - 874
DOI: 10.1126/science.1090187
Prev | Table of Contents | Next

Reports

Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis

Giovanna Mallucci, Andrew Dickinson, Jacqueline Linehan, Peter-Christian Klöhn, Sebastian Brandner, John Collinge*

The mechanisms involved in prion neurotoxicity are unclear, and therapies preventing accumulation of PrPSc, the disease-associated form of prion protein (PrP), do not significantly prolong survival in mice with central nervous system prion infection. We found that depleting endogenous neuronal PrPc in mice with established neuroinvasive prion infection reversed early spongiform change and prevented neuronal loss and progression to clinical disease. This occurred despite the accumulation of extraneuronal PrPSc to levels seen in terminally ill wild-type animals. Thus, the propagation of nonneuronal PrPSc is not pathogenic, but arresting the continued conversion of PrPc to PrPSc within neurons during scrapie infection prevents prion neurotoxicity.

Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1, UK.

* To whom correspondence should be addressed. E-mail: j.collinge{at}prion.ucl.ac.uk

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Prions: Protein Aggregation and Infectious Diseases.
A. Aguzzi and A. M. Calella (2009)
Physiol Rev 89, 1105-1152
   Abstract »    Full Text »    PDF »
Crystal structure of human prion protein bound to a therapeutic antibody.
S. V. Antonyuk, C. R. Trevitt, R. W. Strange, G. S. Jackson, D. Sangar, M. Batchelor, S. Cooper, C. Fraser, S. Jones, T. Georgiou, et al. (2009)
PNAS 106, 2554-2558
   Abstract »    Full Text »    PDF »
Aggregated, Wild-Type Prion Protein Causes Neurological Dysfunction and Synaptic Abnormalities.
R. Chiesa, P. Piccardo, E. Biasini, B. Ghetti, and D. A. Harris (2008)
J. Neurosci. 28, 13258-13267
   Abstract »    Full Text »    PDF »
Molecular and Transmission Characteristics of Primary-Passaged Ovine Scrapie Isolates in Conventional and Ovine PrP Transgenic Mice.
A. M. Thackray, L. Hopkins, J. Spiropoulos, and R. Bujdoso (2008)
J. Virol. 82, 11197-11207
   Abstract »    Full Text »    PDF »
Heat shock factor 1 regulates lifespan as distinct from disease onset in prion disease.
A. D. Steele, G. Hutter, W. S. Jackson, F. L. Heppner, A. W. Borkowski, O. D. King, G. J. Raymond, A. Aguzzi, and S. Lindquist (2008)
PNAS 105, 13626-13631
   Abstract »    Full Text »    PDF »
Prions Impair Bioaminergic Functions through Serotonin- or Catecholamine-derived Neurotoxins in Neuronal Cells.
S. Mouillet-Richard, N. Nishida, E. Pradines, H. Laude, B. Schneider, C. Feraudet, J. Grassi, J.-M. Launay, S. Lehmann, and O. Kellermann (2008)
J. Biol. Chem. 283, 23782-23790
   Abstract »    Full Text »    PDF »
Retrotranslocation of Prion Proteins from the Endoplasmic Reticulum by Preventing GPI Signal Transamidation.
A. Ashok and R. S. Hegde (2008)
Mol. Biol. Cell 19, 3463-3476
   Abstract »    Full Text »    PDF »
A {gamma}-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains.
P. Spilman, P. Lessard, M. Sattavat, C. Bush, T. Tousseyn, E. J. Huang, K. Giles, T. Golde, P. Das, A. Fauq, et al. (2008)
PNAS 105, 10595-10600
   Abstract »    Full Text »    PDF »
Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease.
M. D. White, M. Farmer, I. Mirabile, S. Brandner, J. Collinge, and G. R. Mallucci (2008)
PNAS 105, 10238-10243
   Abstract »    Full Text »    PDF »
Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice.
C.-H. Song, H. Furuoka, C.-L. Kim, M. Ogino, A. Suzuki, R. Hasebe, and M. Horiuchi (2008)
J. Gen. Virol. 89, 1533-1544
   Abstract »    Full Text »    PDF »
Antiprion Prophylaxis by Gene Transfer of a Soluble Prion Antagonist.
N. Genoud, D. Ott, N. Braun, M. Prinz, P. Schwarz, U. Suter, D. Trono, and A. Aguzzi (2008)
Am. J. Pathol. 172, 1287-1296
   Abstract »    Full Text »    PDF »
Physiology of the Prion Protein.
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani (2008)
Physiol Rev 88, 673-728
   Abstract »    Full Text »    PDF »
Prion Diseases: From Protein to Cell Pathology.
G. G. Kovacs and H. Budka (2008)
Am. J. Pathol. 172, 555-565
   Abstract »    Full Text »    PDF »
Normal prion protein trafficking in cultured human erythroblasts.
R. E. Griffiths, K. J. Heesom, and D. J. Anstee (2007)
Blood 110, 4518-4525
   Abstract »    Full Text »    PDF »
A General Model of Prion Strains and Their Pathogenicity.
J. Collinge and A. R. Clarke (2007)
Science 318, 930-936
   Abstract »    Full Text »    PDF »
Mechanistic Insights into the Cure of Prion Disease by Novel Antiprion Compounds.
S. Webb, T. Lekishvili, C. Loeschner, S. Sellarajah, F. Prelli, T. Wisniewski, I. H. Gilbert, and D. R. Brown (2007)
J. Virol. 81, 10729-10741
   Abstract »    Full Text »    PDF »
Prion Protein Expression Differences in Microglia and Astroglia Influence Scrapie-Induced Neurodegeneration in the Retina and Brain of Transgenic Mice.
L. Kercher, C. Favara, J. F. Striebel, R. LaCasse, and B. Chesebro (2007)
J. Virol. 81, 10340-10351
   Abstract »    Full Text »    PDF »
Modulation of Proteinase K-resistant Prion Protein in Cells and Infectious Brain Homogenate by Redox Iron: Implications for Prion Replication and Disease Pathogenesis.
S. Basu, M. L. Mohan, X. Luo, B. Kundu, Q. Kong, and N. Singh (2007)
Mol. Biol. Cell 18, 3302-3312
   Abstract »    Full Text »    PDF »
Disease Mechanisms in Neuroscience.
(2007)
Neuroscientist 13, 302
   PDF »
Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation.
K.-J. Lee, A. Panzera, D. Rogawski, L. E. Greene, and E. Eisenberg (2007)
J. Cell Sci. 120, 2663-2671
   Abstract »    Full Text »    PDF »
Neurotoxic and Gliotrophic Activity of a Synthetic Peptide Homologous to Gerstmann-Straussler-Scheinker Disease Amyloid Protein.
L. Fioriti, N. Angeretti, L. Colombo, A. De Luigi, A. Colombo, C. Manzoni, M. Morbin, F. Tagliavini, M. Salmona, R. Chiesa, et al. (2007)
J. Neurosci. 27, 1576-1583
   Abstract »    Full Text »    PDF »
N-Terminally Deleted Forms of the Prion Protein Activate Both Bax-Dependent and Bax-Independent Neurotoxic Pathways.
A. Li, S. J. Barmada, K. A. Roth, and D. A. Harris (2007)
J. Neurosci. 27, 852-859
   Abstract »    Full Text »    PDF »
Early and Rapid Engraftment of Bone Marrow-Derived Microglia in Scrapie..
J. Priller, M. Prinz, M. Heikenwalder, N. Zeller, P. Schwarz, F. L. Heppner, and A. Aguzzi (2006)
J. Neurosci. 26, 11753-11762
   Abstract »    Full Text »    PDF »
Overstimulation of PrPC Signaling Pathways by Prion Peptide 106-126 Causes Oxidative Injury of Bioaminergic Neuronal Cells.
M. Pietri, A. Caprini, S. Mouillet-Richard, E. Pradines, M. Ermonval, J. Grassi, O. Kellermann, and B. Schneider (2006)
J. Biol. Chem. 281, 28470-28479
   Abstract »    Full Text »    PDF »
A systematic review of prion therapeutics in experimental models.
C. R Trevitt and J. Collinge (2006)
Brain 129, 2241-2265
   Abstract »    Full Text »    PDF »
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice.
S. Le Corre, H. W. Klafki, N. Plesnila, G. Hubinger, A. Obermeier, H. Sahagun, B. Monse, P. Seneci, J. Lewis, J. Eriksen, et al. (2006)
PNAS 103, 9673-9678
   Abstract »    Full Text »    PDF »
Amyloid Fibrils of Mammalian Prion Protein Are Highly Toxic to Cultured Cells and Primary Neurons.
V. Novitskaya, O. V. Bocharova, I. Bronstein, and I. V. Baskakov (2006)
J. Biol. Chem. 281, 13828-13836
   Abstract »    Full Text »    PDF »
Emerging pharmacotherapies for creutzfeldt-jakob disease..
C. Korth and P. J. Peters (2006)
Arch Neurol 63, 497-501
   Abstract »    Full Text »    PDF »
Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis.
A. D. Steele, J. G. Emsley, P. H. Ozdinler, S. Lindquist, and J. D. Macklis (2006)
PNAS 103, 3416-3421
   Abstract »    Full Text »    PDF »
Developing therapeutics for the diseases of protein misfolding.
B. C.H. May, C. Govaerts, and F. E. Cohen (2006)
Neurology 66, S118-S122
   Abstract »    Full Text »    PDF »
Disease-related Prion Protein Forms Aggresomes in Neuronal Cells Leading to Caspase Activation and Apoptosis.
M. Kristiansen, M. J. Messenger, P.-C. Klohn, S. Brandner, J. D. F. Wadsworth, J. Collinge, and S. J. Tabrizi (2005)
J. Biol. Chem. 280, 38851-38861
   Abstract »    Full Text »    PDF »
Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
M. Nunziante, C. Kehler, E. Maas, M. U. Kassack, M. Groschup, and H. M. Schatzl (2005)
J. Cell Sci. 118, 4959-4973
   Abstract »    Full Text »    PDF »
Prion clearance in bigenic mice.
J. G. Safar, S. J. DeArmond, K. Kociuba, C. Deering, S. Didorenko, E. Bouzamondo-Bernstein, S. B. Prusiner, and P. Tremblay (2005)
J. Gen. Virol. 86, 2913-2923
   Abstract »    Full Text »    PDF »
Systematic Identification of Antiprion Drugs by High-Throughput Screening Based on Scanning for Intensely Fluorescent Targets.
U. Bertsch, K. F. Winklhofer, T. Hirschberger, J. Bieschke, P. Weber, F. U. Hartl, P. Tavan, J. Tatzelt, H. A. Kretzschmar, and A. Giese (2005)
J. Virol. 79, 7785-7791
   Abstract »    Full Text »    PDF »
Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie.
B. Chesebro, M. Trifilo, R. Race, K. Meade-White, C. Teng, R. LaCasse, L. Raymond, C. Favara, G. Baron, S. Priola, et al. (2005)
Science 308, 1435-1439
   Abstract »    Full Text »    PDF »
Mammalian Prion Protein Suppresses Bax-induced Cell Death in Yeast.
A. Li and D. A. Harris (2005)
J. Biol. Chem. 280, 17430-17434
   Abstract »    Full Text »    PDF »
A Transmembrane Form of the Prion Protein Is Localized in the Golgi Apparatus of Neurons.
R. S. Stewart and D. A. Harris (2005)
J. Biol. Chem. 280, 15855-15864
   Abstract »    Full Text »    PDF »
Neurodegenerative Illness in Transgenic Mice Expressing a Transmembrane Form of the Prion Protein.
R. S. Stewart, P. Piccardo, B. Ghetti, and D. A. Harris (2005)
J. Neurosci. 25, 3469-3477
   Abstract »    Full Text »    PDF »
Calpain and Other Cytosolic Proteases Can Contribute to the Degradation of Retro-translocated Prion Protein in the Cytosol.
X. Wang, F. Wang, M.-S. Sy, and J. Ma (2005)
J. Biol. Chem. 280, 317-325
   Abstract »    Full Text »    PDF »
Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation.
C.-L. Kim, A. Karino, N. Ishiguro, M. Shinagawa, M. Sato, and M. Horiuchi (2004)
J. Gen. Virol. 85, 3473-3482
   Abstract »    Full Text »    PDF »
Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.
C. Crozet, Y.-L. Lin, C. Mettling, C. Mourton-Gilles, P. Corbeau, S. Lehmann, and V. Perrier (2004)
J. Cell Sci. 117, 5591-5597
   Abstract »    Full Text »    PDF »
PrPSc Binding Antibodies Are Potent Inhibitors of Prion Replication in Cell Lines.
V. Beringue, D. Vilette, G. Mallinson, F. Archer, M. Kaisar, M. Tayebi, G. S. Jackson, A. R. Clarke, H. Laude, J. Collinge, et al. (2004)
J. Biol. Chem. 279, 39671-39676
   Abstract »    Full Text »    PDF »
Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
S. Cronier, H. Laude, and J.-M. Peyrin (2004)
PNAS 101, 12271-12276
   Abstract »    Full Text »    PDF »
Cell Surface Expression of the Prion Protein in Yeast Does Not Alter Copper Utilization Phenotypes.
A. Li, J. Dong, and D. A. Harris (2004)
J. Biol. Chem. 279, 29469-29477
   Abstract »    Full Text »    PDF »
Intrinsic Resistance of Oligodendrocytes to Prion Infection.
M. Prinz, F. Montrasio, H. Furukawa, M. E. van der Haar, P. Schwarz, T. Rulicke, O. T. Giger, K.-G. Hausler, D. Perez, M. Glatzel, et al. (2004)
J. Neurosci. 24, 5974-5981
   Abstract »    Full Text »    PDF »
Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo.
L. Solforosi, J. R. Criado, D. B. McGavern, S. Wirz, M. Sanchez-Alavez, S. Sugama, L. A. DeGiorgio, B. T. Volpe, E. Wiseman, G. Abalos, et al. (2004)
Science 303, 1514-1516
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)